全球道德药品市场，依治疗类别、最终用户、地理位置。

Global Ethical Pharmaceuticals Market, By Therapeutic Class, By End User, By Geography .

出版日期: 2024年02月29日 | 出版商:

Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计 2024 年道德药品市场价值为 47.6 亿美元，预计到 2031 年将达到 94.3 亿美元，2024 年至 2031 年年复合成长率(CAGR) 为 10.3%。

报告范围		报告详情
基准年：	2023年	2023/2024 年市场规模：	47.6 亿美元
历史数据：	2019年至2023年	预测期：	2024年至2031年
预测期间 2023/2024 至 2030/2031 年复合成长率：	10.30%	2030/2031 价值预测：	94.3 亿美元

全球道德药品市占率 (%)，按地区，2024 年

道德药品市场专注于开发和製造具有强大功效和安全性的药物，同时保持高标准的道德、永续性和企业社会责任。这个快速增长的细分市场是由消费者对负责任的製药实践的认识不断提高以及对通过透明的临床试验测试的药物的偏好所推动的，这些药物可以最大限度地减少对人类健康的风险。随着道德标准在患者和医疗保健提供者中变得越来越重要，越来越多的製药商正在接受道德研究、知情同意、环境管理和公平定价的原则，以在这个市场上获得竞争优势。

市场动态：

道德药品市场主要是由对安全、永续生产和经过道德测试的药物不断增长的需求所推动的。围绕临床试验和製造实践的严格监管规范也推动了这一领域的发展。此外，领先的创新公司增加对伦理药物开发的投资也带来了利润丰厚的机会。然而，与道德合规和永续发展措施相关的高成本仍然是市场参与者面临的主要挑战。此外，仿製药竞争日益激烈导致的定价压力也可能成为一种限制。采用区块链和人工智慧平台来提高透明度是实现跨价值链即时资料共享的另一个关键趋势。

研究的主要特点：

该报告对全球伦理药品市场进行了深入分析，并提供了预测期（2024-2031）的市场规模和年复合成长率（CAGR%），以2023年为基准年。
它阐明了不同细分市场的潜在收入成长机会，并解释了该市场有吸引力的投资主张矩阵。
这项研究还提供了有关市场驱动因素、限制因素、机会、新产品发布或批准、市场趋势、区域前景以及主要参与者采取的竞争策略的重要见解。
它根据以下参数（例如公司亮点、产品组合、主要亮点、财务表现和策略）对全球伦理药品市场的主要参与者进行了介绍。
本研究涵盖的主要公司包括雅培实验室、艾伯维公司、强生公司、罗氏公司、安进公司、默克公司、葛兰素史克公司、赛诺菲公司、诺华公司、大冢控股公司、礼来公司、梯瓦製药工业有限公司、辉瑞公司和武田製药公司。
该报告的见解将使行销人员和公司管理当局能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
全球道德药品市场报告迎合了该行业的各个利益相关者，包括投资者、供应商、产品製造商、分销商、新进业者和财务分析师。
利害关係人可以透过用于分析全球道德药品市场的各种策略矩阵轻鬆做出决策。

介绍
北美洲
我们
加拿大
欧洲
英国
德国
义大利
法国
西班牙
俄罗斯
欧洲其他地区
亚太地区
中国
印度
日本
澳洲
韩国
东协
亚太其他地区
拉丁美洲
巴西
墨西哥
阿根廷
拉丁美洲其他地区
中东
海湾合作委员会
以色列
中东其他地区
非洲
南非
北非
中非

第 7 章：公司简介 - 全球道德药品市场

Amgen Inc
- 公司简介
- 产品/服务组合
- 财务绩效
- 最新动态/更新
- 战略概览
AbbVie Inc
Johnson & Johnson
Eli Lilly and Company
Merck & Co., Inc
GlaxoSmithKline plc
Sanofi
Novartis AG
Abbott Laboratories
Otsuka Holdings
F. Hoffmann-La Roche Ltd
Teva Pharmaceutical Industries Ltd.
Pfizer Inc
Takeda Pharmaceutical Company

第 8 章：参考文献与研究方法

参考
研究方法论

简介目录

Product Code: CMI6701

The ethical pharmaceuticals market is estimated to be valued at USD 4.76 Bn in 2024 and is expected to reach USD 9.43 Bn by 2031, growing at a compound annual growth rate (CAGR) of 10.3% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2023/2024:	US$ 4.76 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2023/2024 to 2030/2031 CAGR:	10.30%	2030/2031 Value Projection:	US$ 9.43 Bn

Global Ethical Pharmaceuticals Market Share (%), By Region, 2024

Global Ethical Pharmaceuticals Market - IMG1

The ethical pharmaceuticals market focuses on developing and manufacturing drugs with strong efficacy and safety profiles while maintaining high standards of ethics, sustainability, and corporate social responsibility. This rapidly growing segment is driven by increasing consumer awareness about responsible pharmaceutical practices and preference for medications tested through transparent clinical trials that minimize risk to human health. As ethical standards assume greater significance among patients and healthcare providers, more drug makers are embracing principles of ethical research, informed consent, environmental stewardship, and fair pricing to gain a competitive edge in this market.

Market Dynamics:

The ethical pharmaceuticals market is primarily driven by growing demand for safe, sustainably-produced, and ethically-tested drugs. Stringent regulatory norms around clinical trials and manufacturing practices are also boosting this segment. Additionally, increasing investments by leading innovator companies in ethical drug development present lucrative opportunities. However, the high costs associated with ethics compliance and sustainability initiatives remain a major challenge for market participants. Moreover, pricing pressures due to growing generics competition can act as a restraint. Adoption of blockchain and artificial intelligence enabled platforms for transparency is another key trend enabling real-time data sharing across value chains.

Key Features of the Study:

This report provides an in-depth analysis of the global ethical pharmaceuticals market, and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global ethical pharmaceuticals market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies
The key companies covered as a part of this study include Abbott Laboratories, AbbVie Inc, Johnson & Johnson, F. Hoffmann-La Roche Ltd, Amgen Inc, Merck & Co., Inc, GlaxoSmithKline plc, Sanofi, Novartis AG, Otsuka Holdings, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Pfizer Inc, and Takeda Pharmaceutical Company
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global ethical pharmaceuticals market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global ethical pharmaceuticals market

Detailed Segmentation:

By Therapeutic Class:
- Hormonal Contraceptives
- Respiratory Agents
- Lipid Regulators
- Calcium Antagonists
- ACE Inhibitors
- Narcotic Analgesics
- Others
By End User:
- Hospitals & Clinics
- Pharmaceutical Companies
- Others
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Amgen Inc
- AbbVie Inc
- Johnson & Johnson
- Eli Lilly and Company
- Merck & Co., Inc
- GlaxoSmithKline plc
- Sanofi
- Novartis AG
- Abbott Laboratories
- Otsuka Holdings
- Hoffmann-La Roche Ltd
- Teva Pharmaceutical Industries Ltd.
- Pfizer Inc
- Takeda Pharmaceutical Company

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, by Therapeutic Class
- Market Snapshot, By End User
- Market Snapshot, By Region
- Market Scenario - Conservative, Likely, Opportunistic
Market Opportunity Map

3. Key Insights

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Pest Analysis
Porters Analysis
Technological Advancements
Merger, Acquisition, and Collaboration Scenario
Recent Product Approvals
Company Market Share Analysis
Pricing Analysis
Product Recalls
Pipeline Analysis

4. Global Ethical Pharmaceuticals Market, Therapeutic Class, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2020 - 2031
- Segment Trends
Hormonal Contraceptives, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Respiratory Agents, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Lipid Regulators, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Calcium Antagonists, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
ACE Inhibitors, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Narcotic Analgesics, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Others, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

5. Global Ethical Pharmaceuticals Market, End User, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2020 - 2031
- Segment Trends
Hospitals & Clinics, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Pharmaceutical Companies, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Others, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

6. Global Ethical Pharmaceuticals Market, By Region, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031, (US$ Billion)
- Market Y-o-Y Growth Comparison (%), 2020 - 2031, (US$ Billion)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, Therapeutic Class, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, Therapeutic Class, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
U.K.
Germany
Italy
France
Spain
Russia
Rest Of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, Therapeutic Class, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
China
India
Japan
Australia
South Korea
Asean
Rest Of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, Therapeutic Class, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, Therapeutic Class, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
GCC
Israel
Rest Of The Middle East
Africa
- Introduction
- Market Size and Forecast, Therapeutic Class, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country/Region, 2019 - 2031, (US$ Billion)
South Africa
North Africa
Central Africa

7. Company Profiles - Global Ethical Pharmaceuticals Market

Amgen Inc*
- Company Overview
- Product/Service Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategic Overview
AbbVie Inc
Johnson & Johnson
Eli Lilly and Company
Merck & Co., Inc
GlaxoSmithKline plc
Sanofi
Novartis AG
Abbott Laboratories
Otsuka Holdings
F. Hoffmann-La Roche Ltd
Teva Pharmaceutical Industries Ltd.
Pfizer Inc
Takeda Pharmaceutical Company